Ras and EGFR inhibitors combination therapy

TW202633645APending Publication Date: 2026-08-16ERASCA INC +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114144355
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-11-15
Filing Date
2025-11-13
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001072999_001
    Figure TWG2TA001072999_001
  • Figure TWG2TA001072999_002
    Figure TWG2TA001072999_002
  • Figure TWG2TA001072999_003
    Figure TWG2TA001072999_003
Patent Text Reader

Abstract

The present disclosure relates generally to the use a Pan-RAS or a KRAS inhibitor in combination with an EGFR inhibitor for treating cancer, specifically solid tumors.
Need to check novelty before this filing date? Find Prior Art